An in-depth look to GLYCOREX TRANSPLANTATION B operating, investing, and financing activities

GTAB.B free cash flow for Q2 24 is -1.89 M SEK. For 2023, GTAB.B free cash flow was -12.53 M SEK and operating cash flow was -9.46 M SEK.